A gamma camera re-evaluation of potassium iodide blocking efficiency in mice

Area of Science:

• Nuclear medicine
• Radioprotection
• Pharmacology

Background:

• Thyroid protection from radioiodine is a critical health concern.
• Potassium iodide (KI) is a standard blockade agent, with established dosages from WHO and FDA.
• Previous efficacy studies of KI blockade were conducted in the 1960s and 1970s.

Purpose of the Study:

• To evaluate the effectiveness of scaled potassium iodide (KI) dosages against radioiodine uptake in a mouse model.
• To compare higher KI doses against a standard scaled human dose.
• To assess the utility of a novel, high-resolution gamma camera for biodistribution analysis.

Main Methods:

• Mice were administered varying doses of KI, including a scaled human dose (1X) and higher multiples.
• Radioiodine (125I) biodistribution in the thyroid and whole body was quantified using a novel gamma camera.
• Measurements were taken immediately after exposure, and at 1 and 7 days post-exposure.

Main Results:

• Five times the scaled human KI dose blocked thyroid uptake approximately 40% more effectively than the 1X dose at 1 hour post-exposure.
• Even at 1 and 7 days, the higher KI dose demonstrated about 10% greater blocking efficacy than the 1X dose.
• The novel gamma camera provided precise, whole-body biodistribution data.

Conclusions:

• Higher doses of potassium iodide show enhanced efficacy in blocking radioiodine uptake in mice.
• These findings suggest a need to re-evaluate current KI dosing strategies for radioiodine protection.
• Novel imaging technologies are valuable tools for assessing radioprotective agent efficacy.